Julia TCW, PhD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Pharmacology, Physiology & Biophysics

PhD, Harvard University
AM, Harvard University
BS, Catholic University of Korea

Pronouns: doctor TCW/ Ph.D.: Harvard University



Dr. Julia TCW received Ph.D. and A.M. in Molecular and Cellular Biology from Harvard University with research studies in induced pluripotent stem cell (iPSC) reprogramming in the Department of Stem Cell and Regenerative Biology. She then perused her postdoctoral research in the Department of Neuroscience, Ronald M. Loeb Center for Alzheimer’s Disease, Department of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai, New York with a research focus of the development of iPSC models and study Alzheimer’s disease (AD) genetics. She achieved Druckenmiller Fellowship award from New York Stem Cell Foundation and K, U and R awards from NIH-NIA.

Our research laboratory is aiming at human induced pluripotent stem cell therapeutics. There are two main goals; 1) Deciphering functional mechanisms of Alzheimer’s disease (AD) genetics using in vitro iPSCs and in vivo iPSC/mouse Chimera models and 2) Developing in vitro model systems of human brain for drug screen.

1. Much of our research focuses on the effects of AD genetic risks, especially Apolipoprotein E4 (APOE4), the most significant risk factor for late-onset AD on human brain cell types. Our lab uses the forward genetic, unbiased multi-Omics computational (bioinformatics) approach to uncover pathways and network defects of AD genetic risks and demonstrate molecular mechanisms of the risk factors in CNS cell types derived from CRISPR/Cas9 genome-edited isogenic and population iPSCs. We develop novel computational pipelines to identify molecular and network drivers and integrate genetics and transcriptomics/proteomics for a functional genomic study. In vitro and in vivo work have been focused on efferocytosis, lipid metabolism, matrisome and inflammation in pure human microglia, astrocytes and organoids (multiple brain cell types as a whole) associated with AD genetic risks. Further, our lab is also collaborating with the industry to find a drug target for AD therapeutics.

2. We have developed multiple novel CNS cell type protocols including astrocytes, microglia, pericytes, neural progenitors and glutamatergic neurons and continuously put our effort to advance the 2D models to 3D human brain model to establish efficient platforms for drug screen.

Director of the Laboratory of Human Induced Pluripotent Stem Cell Therapeutics
Boston University Chobanian & Avedisian School of Medicine




Microglia targeted interventions in prodromal Alzheimer's disease stage
08/01/2023 - 05/31/2028 (PI)
NIH/National Institute on Aging
5R01AG083941-02

Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
04/01/2023 - 03/31/2028 (PI)
NIH/National Institute on Aging
3R01AG082362-02S1

Reelin and Receptor Splicing in Alzheimer's Disease
06/01/2024 - 05/31/2027 (Multi-PI)
PI: Julia TCW, PhD
NIH/National Institute on Aging
1RF1AG086313-01

Cholesterol modulation as a therapeutic target for Alzheimer's disease
06/01/2024 - 05/31/2026 (PI)
The Edward N. & Della L. Thome Memorial Foundation


Biology and pathobiology of apoE in aging and Alzheimer's disease - Core E
10/01/2021 - 05/31/2026 (Subcontract PI)
Mayo Clinic Jacksonville NIH NIA
5U19AG069701-04

Deciphering molecular and cellular lipid metabolism of APOE Christchurch variant on human astrocytes of Alzheimer's disease
05/01/2024 - 04/30/2026 (PI)
Ludwig Family Foundation


Modulation of astrocyte matrisome signals reprogram microglia that can be targeted to mitigate Alzheimer's disease
07/01/2022 - 06/30/2025 (PI)
Bright Focus Foundation


Deciphering isogenic APOE isoform dependent neurodegenerative response in human glia
03/01/2022 - 02/28/2025 (PI)
NIH/National Institute on Aging
5K01AG062683-05

Uncovering APOE4 Matrisome endophenotypes using human iPSC-based models
09/15/2022 - 08/31/2024 (PI)
NIH/National Institute on Aging
1R56AG078733-01

Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease
09/30/2021 - 08/31/2024 (Subcontract PI)
Icahn School of Medicine at Mount Sinai NIH NIA
1RF1AG074010-01

Showing 10 of 11 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kloske CM, Belloy ME, Blue EE, Bowman GR, Carrillo MC, Chen X, Chiba-Falek O, Davis AA, Paolo GD, Garretti F, Gate D, Golden LR, Heinecke JW, Herz J, Huang Y, Iadecola C, Johnson LA, Kanekiyo T, Karch CM, Khvorova A, Koppes-den Hertog SJ, Lamb BT, Lawler PE, Guen YL, Litvinchuk A, Liu CC, Mahinrad S, Marcora E, Marino C, Michaelson DM, Miller JJ, Morganti JM, Narayan PS, Naslavsky MS, Oosthoek M, Ramachandran KV, Ramakrishnan A, Raulin AC, Robert A, Saleh RNM, Sexton C, Shah N, Shue F, Sible IJ, Soranno A, Strickland MR, Tcw J, Thierry M, Tsai LH, Tuckey RA, Ulrich JD, van der Kant R, Wang N, Wellington CL, Weninger SC, Yassine HN, Zhao N, Bu G, Goate AM, Holtzman DM. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. Alzheimers Dement. 2024 Jul 19. PMID: 39031528; PMCID: PMC11497726; DOI: 10.1002/alz.13877;
     
  2. Sahelijo N, Rajagopalan P, Qian L, Rahman R, Priyadarshi D, Goldstein D, Thomopoulos SI, Bennett DA, Farrer LA, Stein TD, Shen L, Huang H, Nho K, Andrew SJ, Davatzikos C, Thompson PM, Tcw J, Jun GR. Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer Disease. medRxiv. 2024 Jun 21.View Related Profiles. PMID: 38947056; PMCID: PMC11213108; DOI: 10.1101/2024.06.21.24309255;
     
  3. Wang S, Li B, Cai Z, Hugo C, Li J, Sun Y, Qian L, Remaley AT, Tcw J, Chui HC, Bennett DA, Arvanitakis Z, Kerman B, Yassine H. Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. Res Sq. 2024 May 14. PMID: 38798644; PMCID: PMC11118681; DOI: 10.21203/rs.3.rs-4373201/v1;
     
  4. Saha O, Melo de Farias AR, Pelletier A, Siedlecki-Wullich D, Landeira BS, Gadaut J, Carrier A, Vreulx AC, Guyot K, Shen Y, Bonnefond A, Amouyel P, Tcw J, Kilinc D, Queiroz CM, Delahaye F, Lambert JC, Costa MR. The Alzheimer's disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons. Mol Psychiatry. 2024 Sep; 29(9):2634-2646. PMID: 38514804; PMCID: PMC11420064; DOI: 10.1038/s41380-024-02502-y;
     
  5. Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM. Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease. Ann Neurol. 2024 Apr; 95(4):625-634.View Related Profiles. PMID: 38180638
     
  6. Kloske CM, Barnum CJ, Batista AF, Bradshaw EM, Brickman AM, Bu G, Dennison J, Gearon MD, Goate AM, Haass C, Heneka MT, Hu WT, Huggins LKL, Jones NS, Koldamova R, Lemere CA, Liddelow SA, Marcora E, Marsh SE, Nielsen HM, Petersen KK, Petersen M, Piña-Escudero SD, Qiu WQ, Quiroz YT, Reiman E, Sexton C, Tansey MG, Tcw J, Teunissen CE, Tijms BM, van der Kant R, Wallings R, Weninger SC, Wharton W, Wilcock DM, Wishard TJ, Worley SL, Zetterberg H, Carrillo MC. APOE and immunity: Research highlights. Alzheimers Dement. 2023 Mar 28. PMID: 36975090
     
  7. Kloske CM, Barnum CJ, Batista AF, Bradshaw EM, Brickman AM, Bu G, Dennison J, Gearon MD, Goate AM, Haass C, Heneka MT, Hu WT, Huggins LKL, Jones NS, Koldamova R, Lemere CA, Liddelow SA, Marcora E, Marsh SE, Nielsen HM, Petersen KK, Petersen M, Piña-Escudero SD, Qiu WQ, Quiroz YT, Reiman E, Sexton C, Tansey MG, Tcw J, Teunissen CE, Tijms BM, van der Kant R, Wallings R, Weninger SC, Wharton W, Wilcock DM, Wishard TJ, Worley SL, Zetterberg H, Carrillo MC. APOE and immunity: Research highlights. Alzheimers Dement. 2023 Jun; 19(6):2677-2696. PMID: 36975090
     
  8. Tcw J, Arranz AM. hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer's disease and potential therapeutics. Mol Neurodegener. 2023 Mar 25; 18(1):19. PMID: 36966344; PMCID: PMC10039591; DOI: 10.1186/s13024-023-00612-9;
     
  9. Tcw J, Arranz AM. hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer's disease and potential therapeutics. Mol Neurodegener. 2023 Mar 25; 18(1):19. PMID: 36966344; PMCID: PMC10039591; DOI: 10.1186/s13024-023-00612-9;
     
  10. Leng K, Rose IVL, Kim H, Xia W, Romero-Fernandez W, Rooney B, Koontz M, Li E, Ao Y, Wang S, Krawczyk M, Tcw J, Goate A, Zhang Y, Ullian EM, Sofroniew MV, Fancy SPJ, Schrag MS, Lippmann ES, Kampmann M. CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states. Nat Neurosci. 2022 Nov; 25(11):1528-1542. PMID: 36303069; PMCID: PMC9633461; DOI: 10.1038/s41593-022-01180-9;
     
Showing 10 of 42 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 40 publications over 13 distinct years, with a maximum of 7 publications in 2020 and 2021

YearPublications
20071
20092
20141
20151
20161
20174
20181
20196
20207
20217
20222
20232
20245

2019-2023 NIH: Mentored Research Scientist Career Development Award
2018 Keystone Symposia: National Institute of Neurological Disorders and Stroke (NINDS) Scholarship
2018 5th International Conference on Molecular Neurodegeneration : BrightFocus Foundation travel award
2018 Charleston Conferences on Alzheimer’s Disease (CCAD) : Yong investigator nominee
2017-2019 New York Stem Cell Foundation: Druckenmiller Fellowship
2017 Icahn School of Medicine at Mount Sinai : Promising Young Investigator Award
2016 Alzheimer’s Association International Conference : Postdoctoral Poster Competition Winner Award
2016 Alzheimer’s Association International Conference : Travel fellowship
2015 from Alzheimer’s Drug Discovery Foundation : Young Investigator Scholar travel fellowship
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Alzheimer's disease genetics, Microglia, Astrocytes, Bioinformatics, Human iPSC modeling
Contact for Mentoring:

700 Albany St
Boston MA 02118
Google Map


TCW's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department